High Blood Pressure (Hypertension) Completed Phase 3 Trials for Azilsartan medoxomil (DB08822)

Also known as: HTN / Hypertension(HTN) / Hypertensive / Hypertension / High Blood Pressure / Blood High Pressure / Blood Pressure, High / High Blood Pressures / Blood pressure high / Essential (primary) hypertension / HT / HBP / Hypertension NOS / Hypertension arterial

IndicationStatusPhase
DBCOND0040789 (High Blood Pressure (Hypertension))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02609490Azilsartan in Chinese Patients With Mild and Moderate HypertensionTreatment
NCT00591578Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential HypertensionTreatment
NCT00591773Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential HypertensionTreatment
NCT00591266Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential HypertensionTreatment
NCT00591253Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential HypertensionTreatment
NCT00695955One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionTreatment
NCT00696384A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionTreatment
NCT00696436An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.Treatment
NCT00696241Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionTreatment
NCT00760214Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential HypertensionTreatment
NCT00847626Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionTreatment
NCT02203916Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With HypertensionTreatment